Companies /Consumer Cyclical

Starbucks Corp

NASDAQ: SBUX Restaurants
$95.83
▼ $0.84 (−0.87%) today
Markets closed · 10:35pm ET

SBUX Coverage

Page 20
8:13am ET
Companies and Brands

Nestle Adds Peanut Allergy Treatment to Its Portfolio

Consumer products giant Nestlé has agreed to acquire Aimmune Therapeutics, maker of a peanut-allergy treatment. The deal is valued at $2.6 billion, including Nestlé's existing stake Aimmune.

Paul Ausick